Yosuke Minoda
About Yosuke Minoda
Yosuke Minoda is the WW Scientific Content & Major Markets Clusters Capabilities Lead at Bristol Myers Squibb, with extensive experience in cancer research and immunology.
Title
Yosuke Minoda currently serves as the WW Scientific Content & Major Markets Clusters Capabilities Lead at Bristol Myers Squibb. In this role, he operates across both the UK and Japan, leading key scientific initiatives.
Professional Experience
Yosuke Minoda has a rich background in scientific research and technical roles. His career includes a tenure as Senior Researcher at the Fiona Elsey Cancer Research Institute from 2012 to 2018 in Australia. He also worked as a Technical Officer at Nucleus Network (2011-2013), Research Assistant at Murdoch Children’s Research Institute (2008-2012), and Information Analyst at BioAssayLINK Pty Ltd in 2006.
Education and Expertise
Yosuke Minoda earned a PhD in Cancer Immunology from Fiona Elsey Cancer Research Institute / Federation University, which he completed from 2012 to 2017. Prior to that, he obtained a Bachelor of Biomedical Science with honors in microbiology from The University of Queensland, finishing his studies there in 2006.
Research Contributions
Throughout his career, Yosuke Minoda has been involved in significant research endeavors. He conducted research on rare conditions like Langerhans cell histiocytosis and dyskeratosis congenita. Additionally, he played a key role in developing a cell-based cancer vaccine and contributed to clinical research on diseases such as rheumatoid arthritis, scleroderma, and diabetes.
Project Leadership
Yosuke Minoda led an APAC-wide project that included eight major APAC countries. This project focused on enhancing communication of the global medical strategy and effectively escalating clinical challenges to headquarters. He worked closely with key opinion leaders and investigated over 200 patients in the fields of oncology and immunology.